Gainers
- Orchard Therapeutics ORTX shares increased by 96.5% to $15.99 during Thursday's regular session. As of 13:31 EST, Orchard Therapeutics's stock is trading at a volume of 7.9 million, which is 17105.9% of its average full-day volume over the last 100 days. The company's market cap stands at $363.4 million.
- Histogen HSTO shares moved upwards by 47.17% to $0.75. Trading volume for Histogen's stock is 414.2K as of 13:31 EST. This is 163.7% of its average full-day volume over the last 100 days. The company's market cap stands at $3.1 million.
- Clene CLNN stock moved upwards by 21.0% to $0.6. Trading volume for this security as of 13:31 EST is 2.1 million, which is 481.4% of its average full-day volume over the last 100 days. The company's market cap stands at $76.7 million.
- Orgenesis ORGS stock increased by 19.98% to $0.78. Trading volume for this security as of 13:31 EST is 145.2K, which is 158.0% of its average full-day volume over the last 100 days. The company's market cap stands at $23.7 million.
- Omega Therapeutics OMGA shares increased by 19.4% to $2.06. The current volume of 542.6K shares is 433.9% of Omega Therapeutics's average full-day volume over the last 100 days (last updated at 13:31 EST). The market value of their outstanding shares is at $113.5 million.
- Matinas BioPharma Hldgs MTNB shares increased by 15.85% to $0.14. The current volume of 6.3 million shares is 880.7% of Matinas BioPharma Hldgs's average full-day volume over the last 100 days (last updated at 13:31 EST). The market value of their outstanding shares is at $30.9 million.
Losers
- MaxCyte MXCT shares declined by 22.6% to $2.53 during Thursday's regular session. MaxCyte's stock is trading at a volume of 3.2 million shares as of 13:31 EST. This is 749.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $261.8 million.
- Longeveron LGVN stock decreased by 17.93% to $2.06. The current volume of 9.2 million shares is 7502.9% of Longeveron's average full-day volume over the last 100 days (last updated at 13:31 EST). The company's market cap stands at $43.6 million.
- Viracta Therapeutics VIRX stock declined by 17.39% to $0.76. As of 13:31 EST, Viracta Therapeutics's stock is trading at a volume of 343.5K, which is 439.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $29.3 million.
- Nanobiotix NBTX stock decreased by 17.14% to $7.45. The company's market cap stands at $259.6 million.
- SenesTech SNES stock decreased by 16.29% to $0.37. SenesTech's stock is trading at a volume of 183.9K shares as of 13:31 EST. This is 266.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.1 million.
- Renalytix RNLX stock declined by 16.11% to $1.25. Renalytix's stock is trading at a volume of 98.2K shares as of 13:31 EST. This is 69.2% of its average full-day volume over the last 100 days. The company's market cap stands at $59.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in